Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease.

Kento TakenakaYoshio KitazumeAmi KawamotoToshimitsu FujiiYumi UdagawaRyosuke WanatabeHiromichi ShimizuShuji HibiyaMasakazu NagahoriKazuo OhtsukaHiroyuki SatoAkihiro HirakawaMamoru WatanabeRyuichi Okamoto

Published in: The American journal of gastroenterology (2022)

LRG is a highly accurate serum biomarker for detecting transmural activity in CD patients. Results need to be validated in further multicenter studies.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
peritoneal dialysis
high resolution
cross sectional
patient reported outcomes
double blind